These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1783329)

  • 1. [Effects of intrauterine contraceptive devices (IUD) on rat ovarian steroidogenesis and conception control].
    Tanaka M
    Nihon Yakurigaku Zasshi; 1991 Dec; 98(6):475-81. PubMed ID: 1783329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanism of action of the copper intrauterine device.
    Tamaya T; Nakata Y; Ohno Y; Nioka S; Furuta N
    Fertil Steril; 1976 Jul; 27(7):767-72. PubMed ID: 181276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of intra-uterine contraceptive devices on the oestrogen-induced incorporation of [3H-5]uridine into RNA by the rat uterus.
    Dada OA; Adadevoh BK
    Acta Endocrinol (Copenh); 1976 Jan; 81(1):165-9. PubMed ID: 946138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a copper intrauterine contraceptive device and nylon suture on the estradiol 17beta-6, 7-H3 and progesterone 1, 2-H3 in the rat uterus.
    Ghosh M; Roy SK; Kar AB
    Contraception; 1975 Jan; 11(1):45-51. PubMed ID: 1116359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of levonorgestrel-releasing intrauterine device on hormonal profile and menstrual pattern after long-term use.
    Xiao B; Zeng T; Wu S; Sun H; Xiao N
    Contraception; 1995 Jun; 51(6):359-65. PubMed ID: 7554977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic aspects of IUD action.
    Toder V; Madanes A; Gleicher N
    Contraception; 1988 Apr; 37(4):391-403. PubMed ID: 3383576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of intrauterine progesterone treatment on the endometrial prostaglandin F content in the rabbit.
    Scommegna A; Ilekis J; Sotrel G; Auletta FJ
    Fertil Steril; 1977 May; 28(5):581-6. PubMed ID: 856639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of indomethacin and aminoglutethimide phosphate in vivo on luteinizing-hormone-induced alterations of cyclic adenosine monophosphate, prostaglandin F, and steroid levels in preovulatory rat ovaries.
    Armstrong DT; Dorrington JH; Robinson J
    Can J Biochem; 1976 Sep; 54(9):796-802. PubMed ID: 183880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone-releasing silicone-rubber intrauterine contraceptive devices. Effect of incorporation of various compounds on intrauterine contraceptive devices in rats.
    Doyle LL
    Am J Obstet Gynecol; 1975 Feb; 121(3):405-11. PubMed ID: 1115155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition by indomethacin of increased estradiol extraction by the IUD-containing rat uterine horn.
    Gambone JC; Macri C; Pruyn S; Pardridge W; Chaudhuri G
    Contraception; 1985 Aug; 32(2):191-7. PubMed ID: 4075793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian function during use of a levonorgestrel-releasing IUD.
    Barbosa I; Bakos O; Olsson SE; Odlind V; Johansson ED
    Contraception; 1990 Jul; 42(1):51-66. PubMed ID: 2117516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition by aspirin and indomethacin of uterine hypertrophy induced by an IUD.
    Chaudhuri G
    J Reprod Fertil; 1975 Apr; 43(1):77-81. PubMed ID: 1127641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigestagenic activity of Ixora finlaysoniana in rat.
    Singh MM; Chowdhury SR; Kulshreshtha DK; Kamboj VP
    Contraception; 1993 Aug; 48(2):178-91. PubMed ID: 8403914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rat uterine oestrogen receptor in relation to intra-uterine devices and the oestrous cycle [proceedings].
    Myatt L; Elder MG; Chaudhuri G; Lim L
    Biochem Soc Trans; 1977; 5(5):1563-4. PubMed ID: 562796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the IUD on ovarian activitiy in the hamster and rat.
    Bo WJ; Krueger WA; Bartley CM
    J Reprod Fertil; 1976 Sep; 48(1):229-31. PubMed ID: 966233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of plasminogen activator in human uterine tissue induced by intrauterine contraceptive devices.
    Shaw ST; Macaulay LK; Sun NC; Tanaka MS; Roche PC
    Contraception; 1983 Feb; 27(2):131-40. PubMed ID: 6682747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodegradable polylactate as a steroid-releasing polymer: intrauterine administration of d-norgestrel.
    Nilsson CG; Johansson ED; Jackanicz TM; Luukkainen T
    Am J Obstet Gynecol; 1975 May; 122(1):90-5. PubMed ID: 1130448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum ovarian steroids, prolactin and prostaglandin metabolites in women using the inert intrauterine device.
    Shalev E; Harpaz-Kerpel S; Engelhard Y; Weiner E; Eran A; Zuckerman H
    Int J Gynaecol Obstet; 1987 Apr; 25(2):139-44. PubMed ID: 2884139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian pregnancy in association with an intrauterine device.
    de Vries K; Shapiro I; Degani S; Levitan Z; Mitrani A; Sharf M
    Int J Gynaecol Obstet; 1983 Feb; 21(1):65-70. PubMed ID: 6133796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.